You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 16, Issue 2

February 2023 - 194 articles

Cover Story: Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer, making up about 85% of all lung cancer cases. Tumour angiogenesis has been intensely studied as a target for NSCLC treatment and several anti-angiogenic drugs, such as recombinant endostatin (RE), have been proposed to induce tumour growth inhibition with mixed results. Recently, a renewed interest in RE has emerged, due to its ability to create a vascular normalization window, which results in radiosensitivity enhancement by improving the hypoxic tumour microenvironment. This review provides a timely overview of preclinical and clinical studies that combine RE and radiotherapy for NSCLC treatment, while highlighting the ongoing challenges that must be overcome in order to maximize the benefits of this treatment; as well as the potential advantage of combinations with particle therapy. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (194)

  • Review
  • Open Access
21 Citations
8,680 Views
19 Pages

Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development

  • Chia-Ju Hsieh,
  • Sam Giannakoulias,
  • E. James Petersson and
  • Robert H. Mach

18 February 2023

The use of computer-aided drug design (CADD) for the identification of lead compounds in radiotracer development is steadily increasing. Traditional CADD methods, such as structure-based and ligand-based virtual screening and optimization, have been...

  • Article
  • Open Access
16 Citations
6,026 Views
12 Pages

Cyclotron-Based Production of 67Cu for Radionuclide Theranostics via the 70Zn(p,α)67Cu Reaction

  • Santiago Andrés Brühlmann,
  • Martin Walther,
  • Martin Kreller,
  • Falco Reissig,
  • Hans-Jürgen Pietzsch,
  • Torsten Kniess and
  • Klaus Kopka

17 February 2023

Theranostic matched pairs of radionuclides have aroused interest during the last couple of years, and in that sense, copper is one element that has a lot to offer, and although 61Cu and 64Cu are slowly being established as diagnostic radionuclides fo...

  • Article
  • Open Access
11 Citations
3,548 Views
18 Pages

Therapeutic Effect of Costunolide in Autoimmune Hepatitis: Network Pharmacology and Experimental Validation

  • Zheng Huang,
  • Shangshu Nie,
  • Shuhui Wang,
  • Han Wang,
  • Jin Gong,
  • Wei Yan,
  • Dean Tian and
  • Mei Liu

17 February 2023

Novel treatments for autoimmune hepatitis (AIH) are highly demanded due to the limitations of existing therapeutic agents. Costunolide is a promising candidate due to its anti-inflammatory and hepatoprotective function, but its effect in AIH remains...

  • Review
  • Open Access
28 Citations
6,015 Views
26 Pages

PSMA-Targeted Nanotheranostics for Imaging and Radiotherapy of Prostate Cancer

  • Niranjan Meher,
  • Henry F. VanBrocklin,
  • David M. Wilson and
  • Robert R. Flavell

17 February 2023

Targeted nanotheranostic systems offer significant benefits due to the integration of diagnostic and therapeutic functionality, promoting personalized medicine. In recent years, prostate-specific membrane antigen (PSMA) has emerged as an ideal theran...

  • Review
  • Open Access
7 Citations
3,275 Views
14 Pages

Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review

  • Joana Gorica,
  • Maria Silvia De Feo,
  • Ferdinando Corica,
  • Marko Magdi Abdou Sidrak,
  • Miriam Conte,
  • Luca Filippi,
  • Orazio Schillaci,
  • Giuseppe De Vincentis and
  • Viviana Frantellizzi

17 February 2023

Background: With the high mortality rate of malignant tumors, there is a need to find novel theranostic approaches to provide an early diagnosis and targeted therapy. The chemokine receptor 4 (CCR4) is highly expressed in various tumors and plays an...

  • Review
  • Open Access
7 Citations
5,685 Views
17 Pages

Protein Interactome of Amyloid-β as a Therapeutic Target

  • Vladimir F. Lazarev,
  • Elizaveta A. Dutysheva,
  • Igor E. Kanunikov,
  • Irina V. Guzhova and
  • Boris A. Margulis

16 February 2023

The amyloid concept of Alzheimer’s disease (AD) assumes the β-amyloid peptide (Aβ) as the main pathogenic factor, which injures neural and other brain cells, causing their malfunction and death. Although Aβ has been documented to...

  • Review
  • Open Access
9 Citations
4,855 Views
26 Pages

Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases

  • Joana Torres,
  • Inês Costa,
  • Andreia F. Peixoto,
  • Renata Silva,
  • José Manuel Sousa Lobo and
  • Ana Catarina Silva

16 February 2023

Marine sources contain several bioactive compounds with high therapeutic potential, such as remarkable antioxidant activity that can reduce oxidative stress related to the pathogenesis of neurodegenerative diseases. Indeed, there has been a growing i...

  • Article
  • Open Access
5 Citations
3,358 Views
23 Pages

3D-Printing of Capsule Devices as Compartmentalization Tools for Supported Reagents in the Search of Antiproliferative Isatins

  • Camilla Malatini,
  • Carlos Carbajales,
  • Mariángel Luna,
  • Osvaldo Beltrán,
  • Manuel Amorín,
  • Christian F. Masaguer,
  • José M. Blanco,
  • Silvia Barbosa,
  • Pablo Taboada and
  • Alberto Coelho

16 February 2023

The application of high throughput synthesis methodologies in the generation of active pharmaceutical ingredients (APIs) currently requires the use of automated and easily scalable systems, easy dispensing of supported reagents in solution phase orga...

  • Article
  • Open Access
16 Citations
5,212 Views
10 Pages

Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy

  • Barbara Ruaro,
  • Ilaria Gandin,
  • Riccardo Pozzan,
  • Stefano Tavano,
  • Chiara Bozzi,
  • Michael Hughes,
  • Metka Kodric,
  • Rossella Cifaldi,
  • Selene Lerda and
  • Marco Confalonieri
  • + 3 authors

16 February 2023

Idiopathic pulmonary fibrosis (IPF) is a rare and severe disease with a median survival of ~3 years. Nintedanib (NTD) has been shown to be useful in controlling interstitial lung disease (ILD) in IPF. Here we describe the experience of NTD use in IPF...

  • Article
  • Open Access
9 Citations
3,527 Views
11 Pages

Coupling of NIR Spectroscopy and Chemometrics for the Quantification of Dexamethasone in Pharmaceutical Formulations

  • Alessandra Biancolillo,
  • Claudia Scappaticci,
  • Martina Foschi,
  • Claudia Rossini and
  • Federico Marini

16 February 2023

Counterfeit or substandard drugs are pharmaceutical formulations in which the active pharmaceutical ingredients (APIs) have been replaced or ingredients do not comply with the drug leaflet. With the outbreak of the COVID-19 pandemic, fraud associated...

of 20

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247